FDA approves first-of-its-kind GSK drug

The latest stories trending on MedCity News.

Editor's Pick

Top Story GSK Gets FDA Nod for Drug Treating Anemia From Chronic Kidney Disease The FDA approved GSK drug Jesduvroq for treating anemia in patients with chronic kidney disease. The once-daily pill is the first oral medicine to pass FDA muster in this indication, giving patients a more convenient alternative to injectable anemia therapies. Your Chance to Save $600 Ends Friday 2/3 Don't miss your opportunity to experience the premier networking event in healthcare. Join us May 22-24, 2023 at the Ritz Carlton in Chicago and get access to exclusive networking opportunities, mingle with investors and cutting edge startups, Ask CIOs, and so much more. Register Now

Featured News

Report: Nurse Understaffing Is Becoming More Deadly for Patients More than 90% of nurses in Michigan believe that understaffing is negatively affecting the quality of care they're able to provide, according to a new report. The percentage of respondents who know of a patient death being caused by nurses being assigned too many patients nearly doubled in the past seven years — from 22% in 2016 to 42% in 2023. MA Plans Rejected 2M Prior Authorization Requests in 2021 There were more than 35 million prior authorization requests submitted to MA plans in 2021, and 2 million were denied, according to KFF. Of those denied, just 11% were appealed. However, most of those appeals led to the denial being overturned. NY Innovation Report Shows Funding Plummet for Women's Health; Biotech Startups Gain Interest New York healthcare startups received $3.9 billion of funding in 2022, compared to $9 billion in 2021, according to a new DHNY report. Biotech startups represented 22% of total funding in 2022, a stark difference from women's health only representing 2%. Karuna Picks Up Kidney Drugs for Chance to Challenge Boehringer Ingelheim in the Brain Karuna Therapeutics has licensed two small molecules that shuttering Goldfinch Bio had developed for kidney disorders. These compounds target a pathway that could also treat neurological disorders, giving clinical-stage Karuna the opportunity to compete against a drug candidate from Boehringer Ingelheim. Why Lawmakers Are Trying to Nix VA's $50B+ Dollar Oracle Cerner EHR Rollout Two Congresspeople recently introduced a bill seeking to terminate the VA's Oracle Cerner EHR rollout. The legislation said that the project is too flawed and costly to carry on — the lawmakers called for VA facilities to revert back to the department's internally developed EHR. What A Nobel Prize-Winner's Research Means for Cancer Treatment Drs. Carolyn Bertozzi, Barry Sharpless, and Morten Meldal shared the 2022 Nobel Prize in Chemistry for greatly simplifying the synthesis of complicated molecules. Dr. Bertozzi's protégé writes why her research is so important. 'A Proactive and Necessary Step:' NFPRHA Applauds Proposed Rule on Birth Control Coverage Under the proposed new rule, employers are no longer able to be exempt from covering contraception due to moral convictions, but religious exemptions still remain. It's an important move from the government during the reproductive health crisis, one advocate said. Expanding Telehealth Access Not Reducing it Will Continue Saving Lives, Mitigating Costs of the Opioid Crisis Protectionism against (and fear of) telehealth on display from companies like Walmart and states like Alabama threaten the only effective and scalable solution to America's opioid epidemic.

Resources

Clinical Trial Design E-Book This eBook highlights how contract research organizations are collaborating with technology developers, the role that digital therapeutics could play in clinical trials, how companies are thinking about clinical trial diversity and the challenges in using real-world evidence to replicate clinical trials.   Download Now

MedCity News • 611 Broadway • New York, NY unsubscribe